The limitations of this study include the relative short duration of the xenograft experiments, the inability of NF1 manipulation to directly impact SHP099 sensitivity, and the lack of comprehensive investigation of other mutations impacting SHP2-inhibitor sensitivity in NB. Here, NF1 is linked to neuroblastoma.